Nifty Tips : Shares of Glenmark Pharma increased 1.7 percent intraday on receiving final approval from the USFDA for its extended cycle oral contraceptives. The pharma company has received final approval from the US Food and Drug Administration (USFDA) for the extended cycle oral contraceptive, Levonorgestrel & Ethinyl Estradiol tablets USP, 0.15 mg. 0.03 mg, the AB-rated generic version of seasonable by Teva Women's Health. Seasonale is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.In accordance with IMS Health sales data for a one year period till April 2015 , the Seasonale market attained annual sales of approx 53.7 million U.S. dollars.
Shares of Eicher Motors increased over 3 percent intraday after CLSA has initiated coverage on the stock with a buy rating and a target price of Rs 21800 per share. The brokerage expects Eicher to deliver sector-leading 52 percent consolidated EPS Cagr over the upcoming three years. Premium valuations should carry given robust outlook and low competitive hazard for Royal Enfield, it adds. Royal Enfield will be a key beneficiary of rising replacement demand and shift in motorcycle demand profiletowards high-quality bikes. Commercial vehicle business should also deliver powerful growth led by commercial cycle recovery and market share gains in heavy truck segment driven by new products this all is what it says in report.